Investment Analysts’ price target changes for Thursday, April 25th: Acrivon Therapeutics (NASDAQ:ACRV) had its target price boosted by JMP Securities from $14.00 to $17.00. They currently have a market outperform rating on the stock. Align Technology (NASDAQ:ALGN) had its price target raised by Morgan Stanley from $344.00 to $360.00. The firm currently has an overweight […]